Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 1;4(11):1616-1617.
doi: 10.1001/jamaoncol.2018.4423.

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy

Rishi Deka  1   2   3 , Daniel R Simpson  1   2   3 , Alex K Bryant  1   2 , Vinit Nalawade  1   2   3 , Rana McKay  1   2 , J D Murphy  1   2   3 , Brent S Rose  1   2   3
Affiliations

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy

Rishi Deka et al. JAMA Oncol. .

Abstract

This cohort study examines the association of androgen deprivation therapy with dementia in male veterans with prostate cancer who receive definitive radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Cohort Flowchart
ADT indicates androgen deprivation therapy; and MCI, mild cognitive impairment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nead KT, Gaskin G, Chester C, et al. . Androgen deprivation therapy and future Alzheimer’s disease risk. J Clin Oncol. 2016;34(6):566-571. doi:10.1200/JCO.2015.63.6266 - DOI - PMC - PubMed
    1. Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association between androgen deprivation therapy and risk of dementia. JAMA Oncol. 2017;3(1):49-55. doi:10.1001/jamaoncol.2016.3662 - DOI - PubMed
    1. Baik SH, Kury FSP, McDonald CJ. Risk of Alzheimer’s disease among senior medicare beneficiaries treated with androgen deprivation therapy for prostate cancer. J Clin Oncol. 2017;35(30):3401-3409. doi:10.1200/JCO.2017.72.6109 - DOI - PMC - PubMed
    1. Khosrow-Khavar F, Rej S, Yin H, Aprikian A, Azoulay L. Androgen deprivation therapy and the risk of dementia in patients with prostate cancer. J Clin Oncol. 2017;35(2):201-207. doi:10.1200/JCO.2016.69.6203 - DOI - PubMed
    1. Williams SB, Huo J, Chamie K, et al. . Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: the limitations of cancer registry data. Cancer. 2017;123(9):1617-1624. doi:10.1002/cncr.30506 - DOI - PMC - PubMed

MeSH terms

Substances